US markets dip as Dow falls for fourth straight day, eyes on US inflation data
11 Dec 2024 - US stocks have closed lower, with the Dow Jones Industrial Average down for the fourth consecutive session.
11Dec
10Dec
Dow dips, Nasdaq slips as chipmakers lead US market retreat
10 Dec 2024 - US markets have pulled back from recent highs, with tech stocks leading the decline.
09Dec
Wall Street hits records as Fed rate cut hopes grow, ANZ names new CEO
09 Dec 2024 - Wall Street ended the week with record highs for the S&P 500 and Nasdaq Composite. The S&P 500 rose 0.25% to 6,090.27, while the Nasdaq climbed 0.81% to 19,859.77, driven by gains in Tesla, Meta, and Amazon.
06Dec
Hot Stocks: Northern Star Resources, Hazer Group, INOVIQ
06 Dec 2024 - A snapshot of the stocks on the move, featuring Northern Star Resources (ASX:NST), GQG Partners (ASX:GQG), Hazer Group (ASX:HZR), INOVIQ (ASX:IIQ) and HMC Capital (ASX:HMC).
05Dec
S&P 500 and Nasdaq reach record highs: ASX to open higher
05 Dec 2024 - The S&P 500 and Nasdaq Composite surged to record highs on Wednesday, driven by strong reports from Salesforce and Marvell Technology, with tech stocks leading the rally.
02Dec
US markets reach new highs; ASX to open higher
02 Dec 2024 - The Dow Jones Industrial Average and S&P 500 hit new highs on Friday, buoyed by President-elect Trump's proposals for tax cuts and regulatory easing.
29Nov
Hot Stocks: Resolute Mining, AVJennings, SG Fleet, Novonix, ASX
29 Nov 2024 - A snapshot of the stocks making headlines this week include Resolute Mining (ASX:RSG), AVJennings (ASX:AVJ), SG Fleet (ASX:SGF), Novonix (ASX:NVX) and ASX (ASX:ASX).
28Nov
US markets dip as Tech stocks struggle; ASX to open higher
28 Nov 2024 - US markets dipped slightly, with tech stocks pressured by disappointing news from Dell, HP, and CrowdStrike.
27Nov
Dow, S&P500 reach new highs; Oil slips; Bitcoin dips below $92K; ASX to rise
27 Nov 2024 - US stocks climbed on Tuesday, with the S&P 500 and the Dow Jones reaching new highs as investors brushed off concerns about potential tariffs from President-elect Donald Trump.
26Nov
Reflecting on progress and partnerships at Immutep
26 Nov 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.